diabetestalk.net

Types Of Insulin Pens In India

Adding Lantus® And Fitting It Into Your Diabetes Treatment Routine

Adding Lantus® And Fitting It Into Your Diabetes Treatment Routine

Being consistent with a schedule helped José with managing his blood sugar. Your routine should include: Administering your Lantus® at the same time every day Checking your blood sugar regularly and keeping a log Keeping your supplies together in a safe place Learning how to balance diet, exercise, insulin and your other medications Tips to Help You Remember If you take Lantus® at night, you might leave a note on your nightstand. If you take it in the morning, leave your Lantus® near your toothbrush. Always carry your Blood Sugar Log with you or get a blood sugar monitor with a built-in memory and record your numbers in your log later. It also helps to be consistent in how you organize your supplies. For example, keep your non-refrigerated supplies all together in one place—say, a kitchen or bathroom cabinet, a linen closet, or a dresser drawer in your bedroom—out of reach of children, of course. Continue reading >>

Insulin Pens

Insulin Pens

Often the size and shape of a large marker, insulin pens carry insulin in a self-contained cartridge. They are easy to use and growing in popularity. Some users use insulin pens for all their injections, while others carry them when they are "on the go" and rely on less-expensive and more versatile syringes when they are: mixing different insulins taking an insulin that is not available in a pen at home Insulin pens are used with pen needles that are sold separately. A new pen needle should be used each time you inject. Insulin Pen Types While there are a number of different brands and models available, most insulin pens fall into one of two groups: reusable pens and disposable pens. Before using a reusable insulin pen, you must load it with a cartridge of insulin. Depending on the size of your doses, a cartridge may give you enough insulin to last for several days of injections. When the cartridge is empty, you throw it away and load a new cartridge. With good care, a reusable pen can often be used for several years. Disposable insulin pens come filled with insulin and are thrown away when they are empty. Disposable pens are generally more convenient than reusable pens because you do not need to load any cartridges, but they usually cost more to use than reusable pens and cartridges. Pen brands and models differ from one another in many ways. When working with your healthcare team to select a pen, there are many factors to keep in mind, including: The brands and types of insulin that are available for the pen. The number of units of insulin that the pen holds when full. The largest size dose that can be injected with the pen. How finely the dose can be adjusted by the pen. For example, one pen may dose in two-unit increments (2, 4, 6, etc.), another in one-unit increme Continue reading >>

Why Is Insulin So Expensive In The U.s.?

Why Is Insulin So Expensive In The U.s.?

Dr. Jeremy Greene sees a lot of patients with diabetes that's out of control. In fact, he says, sometimes their blood sugar is "so high that you can't even record the number on their glucometer." Greene, a professor of medicine and history of medicine at Johns Hopkins University, started asking patients at his clinic in Baltimore why they had so much trouble keeping their blood sugar stable. He was shocked by their answer: the high cost of insulin. Greene decided to call some local pharmacies, to ask about low-cost options. He was told no such options existed. "Only then did I realize there is no such thing as generic insulin in the United States in the year 2015," he says. Greene wondered why that was the case. Why was a medicine more than 90 years old so expensive? He started looking into the history of insulin, and has published a paper about his findings in this week's issue of the New England Journal of Medicine. The story of insulin, it turns out, starts back in the late 1800s. That's when scientists discovered a link between diabetes and damaged cells in the pancreas — cells that produce insulin. In the early 1920s, researchers in Toronto extracted insulin from cattle pancreases and gave it to people who had diabetes, as part of a clinical trial. The first patient was a 14-year-old boy, who made a dramatic recovery. Most others recovered as well. Soon, insulin from pigs and cattle was being produced and sold on a massive scale around the world. But for some, the early forms of the medicine weren't ideal. Many people required multiple injections every day, and some developed minor allergic reactions. Over the next few decades, scientists figured out how to produce higher-quality insulin, Greene says. They made the drug purer, so recipients had fewer bad reaction Continue reading >>

Get Around-the-clock Blood Sugar Control With Powerful A1c Reduction

Get Around-the-clock Blood Sugar Control With Powerful A1c Reduction

Do not take Tresiba® if you: are having an episode of low blood sugar are allergic to Tresiba® or any of the ingredients in Tresiba® Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are: pregnant, planning to become pregnant, or are breastfeeding taking new prescription or over-the-counter medicines, vitamins, or herbal supplements Talk to your health care provider about low blood sugar and how to manage it. Read the Instructions for Use and take Tresiba® exactly as your health care provider tells you to Do not do any conversion of your dose. The dose counter always shows the selected dose in units Know the type and strength of insulin you take. Do not change the type of insulin you take unless your health care provider tells you to Prescription Tresiba® is a long-acting insulin used to control high blood sugar in adults and children who are 1 year of age and older with diabetes Tresiba® is not for people with diabetic ketoacidosis Tresiba® is not for children who need less than 5 units of Tresiba® each day It is not known if Tresiba® is safe and effective in children under 1 year of age Tresiba® is available in 2 concentrations: 200 units/mL and 100 units/mL Do not take Tresiba® if you: are having an episode of low blood sugar are allergic to Tresiba® or any of the ingredients in Tresiba® Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are: pregnant, planning to become pregnant, or are breastfeeding taking new prescription or over-the-counter medicines, vitamins, or herbal supplements Talk to your health care provider about low blood sugar and how to manage it. Read the Instructions for Use and take Tresiba® exactly as your health care pr Continue reading >>

Insulin

Insulin

What are Insulin Insulin is a hormone that occurs naturally in the body and can also be given by injection as a treatment for diabetes. Naturally-occurring insulin is made by the beta cells of the Islets of Langerhans located in the pancreas. It helps the cells of the body to uptake glucose (sugar) found in the carbohydrates we eat so that it can be used as energy or stored for later use. Insulin also controls glucose release from the liver. One of the main roles of insulin is to keep blood glucose levels from going too high (hyperglycemia) or too low (hypoglycemia). People with type 1 diabetes do not make enough insulin to satisfy their body's needs or make none at all. Insulin given by injection acts similarly to naturally occurring insulin. There are more than 20 different types of insulin available for diabetes treatment in the United States. The various types of insulin differ in several ways: such as source (animal, human or genetically engineered), the time for insulin to take effect and the length of time the insulin remains working (ie, rapid acting, short acting, intermediate acting, long acting or very long acting). Insulin is used to treat Type 1 diabetes and it may be used together with oral medications in the later stages of Type 2 diabetes. List of Insulin: Filter by: -- all conditions -- Drug Name View by: Brand | Generic Reviews Avg. Ratings Humulin R (Pro, More...) generic name: insulin regular 0 reviews 10 NovoLog Mix 70 / 30 FlexPen (More...) generic name: insulin aspart/insulin aspart protamine 0 reviews 10 Humalog Mix 75 / 25 (More...) generic name: insulin lispro/insulin lispro protamine 2 reviews 9.5 NovoLog Mix 70 / 30 (More...) generic name: insulin aspart/insulin aspart protamine 3 reviews 9.5 ReliOn / Novolin 70 / 30 (More...) generic name: i Continue reading >>

Insulin

Insulin

Indication BASAGLAR is a long-acting insulin used to control high blood sugar in adults and children with type 1 diabetes and adults with type 2 diabetes. Limitation of Use BASAGLAR is not for treating diabetic ketoacidosis. Important Safety Information Do not take BASAGLAR during episodes of low blood sugar or if you are allergic to insulin glargine or any of the ingredients in BASAGLAR. Do NOT reuse needles or share insulin pens, even if the needle has been changed. Before starting BASAGLAR, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant, or if you are breastfeeding or planning to breastfeed. BASAGLAR should be taken once a day at the same time every day. Test your blood sugar levels while using insulin. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision. The most common side effect of insulin, including BASAGLAR, is low blood sugar (hypoglycemia), which may be serious and life threatening. Signs and symptoms may include dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood change, or hunger. Do NOT dilute or mix BASAGLAR with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. BASAGLAR must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection. BASAGLAR may cause serious side effects that can lead to death, such as severe allergic reactions. Get emergency help if you have: Heart fa Continue reading >>

Sanofi Launches Re-usable Insulin Pen Priced Rs 650 - Business Line

Sanofi Launches Re-usable Insulin Pen Priced Rs 650 - Business Line

Sanofi launches re-usable insulin pen priced Rs 650 Volker Korger (right), Director-Diabetes Device Projects Global Medical Device Development, Sanofi Germany; Shailesh Ayyangar, Managing Director-India & Vice-President - South Asia, Group Sanofi; and Shashank Joshi, Consultant Endocrinologist at Lilavati Hospital, at a press conference in Mumbai on Tuesday. Shashi Ashiwal - Business Line The Indian-arm of French company Sanofi has brought out a re-usable insulin delivery pen completely Made-in-India. It took three years to develop the indigenously made device sold under the AllStar brand name, designed on the feed back of people in India, said Shailesh Ayyangar, Sanofi Indias Managing Director and Vice-President. Priced at Rs 650 per pen, the device is pegged at about 20 per cent less than other similar products in the market, he added. A person with diabetes could use the pen-shaped device by fitting it with a cartridge of Sanofis insulin and injecting themselves. There are queries for AllStar from South-East Asian and African markets, he said, and a regulatory pathway is being worked out to sell in these markets. India is estimated to have about 64 million people with diabetes. The product has been designed in-keeping with the specific needs of the local market, he said. The device will be made in Gujarat. For the Rs 2,000-crore Sanofi India, about Rs 400 crore comes from its diabetes portfolio comprising orally consumed drugs and insulin. Outlining the features of the device, Volker Korger, Sanofis Head - Diabetes Device Projects (Frankfurt), said the device was the slimmest, shortest and lightest of pens available in India. The device is the outcome of a multi-country venture, including Germany, the United Kingdom, Taiwan and India, he said. One of the key feature Continue reading >>

Travel In India With Type 1 Diabetes – Insulin Availability And Pricing

Travel In India With Type 1 Diabetes – Insulin Availability And Pricing

In late July 2011, exactly 7 months after Amy was diagnosed with type 1 diabetes, we backpacked around India for four weeks, in a trip we called Monsoon Meandering. This is post 9 in the series about that trip and its planning and how type 1 diabetes played a part. This post is not borne from experience but from information some of my good friends in India have provided me, following questions asked via the #DOC (Twitter diabetes online community). I’d like to thank my friends Gautam, Madhu and Yogesh for their help in getting me the information for this article. NOTE: If you’re interested in diabetes supplies other than insulin take a look at this post: buying diabetes supplies in India Insulin availability A quick straw poll of some UK Twitter users gave me a list of the most frequently used fast and slow acting insulins: (all sources courtesy of my friend Gautam.) Fast-acting – Novarapid – is available, including flex pens. source Fast-acting – Humalog – is available. source Slow-acting – Lantus – is available. source Slow-acting – Levemir – flex-pens are available, can’t confirm about cartridges. source IMPORTANT UPDATE: Since posting this article last night my friend Gretchen, who is insulin dependant and travelling in India at the moment, has said that she could not find Humalog anywhere in Puri or Kolkata (Calcutta), even though getting it in those places is not meant to be a problem. Bear in mind that whilst Puri is tiny and only has a population of 200,000, Kolkata is a major city with a population of 5 million. Both are on the west coast so perhaps Humalog is not readily available there? Insulin – example pricing Using the sources listed under ‘Insulin availability’ above as of now – 6th January 2013 – the following prices apply Continue reading >>

An Audit Of Insulin Usage And Insulin Injection Practices In A Large Indian Cohort Baruah Mp, Kalra S, Bose S, Deka J - Indian J Endocr Metab

An Audit Of Insulin Usage And Insulin Injection Practices In A Large Indian Cohort Baruah Mp, Kalra S, Bose S, Deka J - Indian J Endocr Metab

Although oral antidiabetic drugs (OADs) remain the mainstay in the treatment of type 2 diabetes mellitus (T2DM), insulin therapy becomes inevitable in a substantial number of patients as the disease progresses. According to recent estimates, roughly 4 of 10 patients with T2DM in India and Gulf countries are using insulin alone or in combination with OADs at any given point of time. [1] , [2] Insulin therapy is an essential part of diabetes management; all type 1 and most type 2 diabetes patients require insulin at some stage. As injectable therapies such as human insulin, insulin analogs, and glucagon-like peptide-1 receptor agonists are used to manage diabetes, correct injection technique is vital for achievement of glycemic control. Specific recommendations to collate and explain best practices in insulin injecting technique are needed for people with diabetes as well as health-care providers (HCPs). [3] Inadequate knowledge regarding insulin usage is likely to influence its acceptance and adherence, and outcome of therapy, underscoring a great need to investigate knowledge, attitude, and practice of insulin use in patients with diabetes, type1 and type 2 alike. Insulin site reactions are common local adverse events of insulin therapy. Lipodystrophy (LD), often caused by repeated reuse of needles, manifests as a localized lesion at the repeated injection site. Chronic reuse of needles and injections at the same site are known contributing factors. LD are divided to two subgroups: lipohypertrophy (LH) and lipoatrophy (LA). LH is a thick soft to firm swelling with rubbery consistency, and LA is a scarring lesion with depression. [3] , [4] , [5] , [6] There was a strong relationship between the presence of LH and improper or lack of rotation of sites, as found in studie Continue reading >>

Long-acting Insulin: How It Works

Long-acting Insulin: How It Works

When you eat, your pancreas releases a hormone called insulin. Insulin moves sugar (glucose) from your blood to your cells for energy or storage. If you take insulin, you may need some at mealtime to help lower your blood sugar after you eat. But even between meals, you need insulin in small amounts to help keep blood sugar stable. This is where long-acting insulin comes in. If you have diabetes, either your pancreas can’t produce enough (or any) insulin, or your cells can’t use it efficiently. To control your blood sugar, you need to replace or supplement the normal function of your pancreas with regular insulin injections. Insulin comes in many types. Each type differs in three ways: onset: how quickly it starts working to lower your blood sugar peak: when its effects on your blood sugar are strongest duration: how long it lowers your blood sugar According to the U.S. Food and Drug Administration (FDA), the five types of insulin are: Rapid-acting insulin: This type starts to work just 15 minutes after you take it. It peaks within 30 to 90 minutes, and its effects last for three to five hours. Short-acting insulin: This type takes about 30 to 60 minutes to become active in your bloodstream. It peaks in two to four hours, and its effects can last for five to eight hours. It is sometimes called regular-acting insulin. Intermediate-acting insulin: The intermediate type takes one to three hours to start working. It peaks in eight hours and works for 12 to 16 hours. Long-acting insulin: This type takes the longest amount of time to start working. The insulin can take up to 4 hours to get into your bloodstream. Pre-mixed: This is a combination of two different types of insulin: one that controls blood sugar at meals and another that controls blood sugar between meals. Lo Continue reading >>

New Insulin On The Market – Insulin Degludec (tresiba)

New Insulin On The Market – Insulin Degludec (tresiba)

News Releases NICE issues Evidence Summaries for Type 1 diabetes and Type 2 diabetes NICE Evidence Summary NICE Evidence summaries are not NICE Guidance but provide summaries of key evidence for selected new medicines that are considered to be of significance to the NHS to provide useful information for those working in the NHS when a new medicine becomes available. NICE has now issued evidence summaries for the new insulin degludec [Tresiba] for Type 1 and Type 2 diabetes in adults over 18 years. Insulin degludec [Tresba] is a long-acting insulin analogue available in 2 strengths: 100units/ml and 200 units/ml. It is a once daily injection with a minimum of 8 hours between injections. It is more expensive than all other long-acting insulins – 5×3 ml cartridges and 5×3 ml pre-filled pen [both 100 units/ml] are £72.00 and 3×3 ml pre-filled pen [200 units/ml] is £86.40. NICE recommends that the cost should be taken into account when prescribing decisions are made. Type 1 diabetes: Insulin degludec [Tresiba] The NICE guidance for Type 1 diabetes [Clinical guideline 15] recommends that basal insulin supply for adults should be NPH (isophane) insulin or a long-acting insulin analogue when nocturnal hypoglycaemia or morning hyperglycaemia is a problem on NPH (isophane) insulin or rapid-acting insulin analogues are used for mealtime blood glucose control. Key points from the Evidence Summary Insulin degludec is non-inferior to insulin glargine in terms of glycaemic control in Type 1 diabetes. There are statistically significantly lower rates of nocturnal hypoglycaemia – 1.4 and 4 episodes per patient per year with insulin degludec compared with Lantus. However, the trials failed to find a difference in the rates of overall, daytime or severe hypoglycaemia. Although the Continue reading >>

Initial Experience And Evaluation Of Reusable Insulin Pen Devices Among Patients With Diabetes In Emerging Countries

Initial Experience And Evaluation Of Reusable Insulin Pen Devices Among Patients With Diabetes In Emerging Countries

Abstract Many individuals with type 2 diabetes in emerging countries are transitioning from vial-and-syringe insulin delivery to that of insulin pens (disposable or reusable). As with all insulin delivery methods, patient preferences and comfort are of utmost importance to optimize adherence to treatment. Patient-preferred characteristics for reusable insulin pens and barriers to appropriate injection, particularly in these regions, have not been widely reported in the clinical literature, highlighting a key information gap for clinicians considering these methods as part of a comprehensive diabetes management approach. Face-to-face interviews were conducted with people with type 1/2 diabetes, including insulin-naïve and established insulin users. After moderator demonstration, participants were evaluated on their ability to perform a six-step process to inject a 10-unit dose into a pad with the AllStar® (AS; Sanofi, Mumbai, India), HumaPen Ergo II® (HE2; Eli Lilly, Indianapolis, USA), and NovoPen 4® (NP4; Novo Nordisk, Bagsværd, Denmark) pens. Local pens were also tested in India, China and Brazil. A total of 503 people from India, Malaysia, Brazil, Egypt, and China participated. Participants completed the six-step process in an average, 2–3 min per pen. Participants ranked ease of overall use and ease of self-injection and dialing/reading dose as most important features for new insulin pens. When using the pens, the most difficult step was priming/safety testing, with 7–12% failing and 28–40% having difficulty; 6%, 18%, and 22% failed to hold the injection button down for the required period of time using AS, NP4, and HE2, respectively. Participants ranked AS significantly higher for nine of 12 ease-of-use features including three of the top four features c Continue reading >>

Is An Insulin Pen Right For You?

Is An Insulin Pen Right For You?

Thinking About Trying an Insulin Pen? For decades, taking insulin required a syringe and a vial. Another option for taking insulin began about 20 years ago when the first insulin pen hit the market. Insulin pens, which look like oversize ink pens, generally contain 300 units of one type of insulin or a fixed combination of two insulins. The pen is a convenient, accurate, and discreet way to take insulin. The ability to quickly and easily deliver a dose of insulin wherever and whenever you need is the pen's biggest advantage. Also, if you lack dexterity in your fingers, an insulin pen might be easier for you to manage than a vial and syringe. "When a person's health plan will cover pens, I try to prescribe them," says cardiologist Steven Nash, M.D., of Manlius, New York. "I think they're much easier to use than syringes." Insulin pens are also great for traveling because they're small and can be kept at room temperature. "My insulin pen has made taking insulin easier," says Marsha LaClair, 41, of Austin, Texas, who has type 1 diabetes. "I travel frequently, and now packing to manage my diabetes is a breeze." Reusable and Disposable Pens Insulin pens fall into two categories: reusable and disposable. Reusable insulin pens use replaceable cartridges filled with insulin; they usually contain 300 units of insulin each. When the cartridge is empty, or if you've stored your pen and cartridge at room temperature for more than 28 days, the cartridge is discarded and a new one is inserted. The more commonly used disposable pens come prefilled with insulin. When the pen is empty or has been stored at room temperature for more than 28 days, discard the whole pen. However, insulin pens do not come with a needle attached. You need to attach an insulin-pen needle to the end of the pen Continue reading >>

Cheapest Insulin Pen In India

Cheapest Insulin Pen In India

Insulin pen is used for injecting insulin in the body of diabetic for treating it. Most of the diabetic care products such as insulin & pen are imported from foreign countries. And since they are highly priced, common man is out of reach. However you can buy cheapest insulin pen in India manufactured by the top pharmaceutical company – Sanofi Aventis under the brand name B D Micro Fine and Insuman 25/75 Optiset. Here are the details of low cost Insulin pen: 1 Insulin (Human)-80 iu/40iu/100iu Pen can be purchased at Rs. 46 Pen Insuman 25/75 Optiset (100 iu) 5 pen costs Rs. 241.33 (Note: Local taxes are not included) Quality wise generic medicines are similar to branded drugs sold by big pharmaceutical companies and do not pose any health risks provided they are prescribed by the doctors. How to Buy Diabetics can buy cheap insulin pen at healthkartplus with following buying options available: 1) Buy directly online at healthkartplus.com OR 2) E-mail [email protected] along with all the product details. And you will get all the products delivered at your doorstep. Make sure to include your correct mailing address, contact number and PIN code. You can then pay by cash upon receiving the product. Products are delivered within 1-2 days (24*7) Save Money on Diabetes Treatment Apart from buying cheap insulin pen, diabetics can save money on their healthcare costs: Purchasing medicines in bulk as you’ll get discount Buy online as medicines are sold at cheaper rates Many sites also run offers for returning customers. Even if they don’t then you should ask them to provide discounts for all the purchase made Compare prices online at various websites and then buy Always ask your doctor for generic substitute for the prescribed drug Continue reading >>

Insulin Pen

Insulin Pen

Two types of modern, pre-filled insulin syringes. An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. It was introduced and marketed as NovoPen by the Danish company Novo Nordisk in 1985. Types of pens[edit] A number of companies make insulin pens including Novo Nordisk, Aventis, Eli Lilly and Biocon. These companies produce pens for most of their insulins, including NovoLog/NovoRapid, Humalog, Levemir and Lantus. There are two pen systems: durable and prefilled: A durable pen uses a replaceable insulin cartridge. When the insulin cartridge is empty, the empty cartridge is disposed of and a new one is inserted in the pen. A prefilled pen is entirely disposable. The pen comes pre-filled with insulin, and when the insulin cartridge or reservoir is empty, the entire unit is discarded. Most brands of insulin are now available for use in pens, these include: NovoMix, NovoRapid and Levemir by Novo Nordisk Lantus and Apidra by Sanofi-Aventis Humulin and Humalog by Eli Lilly and Company INSUGEN and BASALOG by Biocon Global Patient Uptake[edit] Insulin pens are used by 95% of insulin-treated patients in Europe, Asia, Australia and Scandinavia with excellent results.[1] They are currently underutilized but growing in use in the United States. Insulin pens offer several significant advantages over insulin syringes: ease of handling, accuracy, and they are more discreet to use and easier to transport. To use an insulin pen[edit] How to prime an insulin pen. Screw or click on a new pen needle. If necessary, prime the pen to remove any air from the needle Continue reading >>

More in insulin